(2003). Ibritumomab tiuxetan (Zevalin) in non-Hodgkin's lymphoma: Clinical background, practical considerations, and case studies / edited by Bruce D. Cheson.
Čikaški stil citiranja (17. izdanje)Ibritumomab Tiuxetan (Zevalin) in Non-Hodgkin's Lymphoma: Clinical Background, Practical Considerations, and Case Studies / Edited by Bruce D. Cheson. 2003.
MLA način citiranja (9. izdanje)Ibritumomab Tiuxetan (Zevalin) in Non-Hodgkin's Lymphoma: Clinical Background, Practical Considerations, and Case Studies / Edited by Bruce D. Cheson. 2003.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.